Acasti Pharma Stock Price, News & Analysis
ACST
NASDAQ
Company Description
Welcome to the overview page for Acasti Pharma (ACST), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Acasti Pharma.
Financial Highlights
-$3,432,000
Net Income (TTM)
-$0.30
-$4,239,000
Operating Cash Flow
6.01
-$4,831,000
—
Revenue (TTM)
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Acasti Pharma (ACST)?
The current stock price of Acasti Pharma (ACST) is $3.409 as of February 7, 2025.
What is the market cap of Acasti Pharma (ACST)?
The market cap of Acasti Pharma (ACST) is approximately 34.2M. Learn more about what market capitalization means .
What is the net income of Acasti Pharma (ACST)?
The trailing twelve months (TTM) net income of Acasti Pharma (ACST) is -$3,432,000.
What is the earnings per share (EPS) of Acasti Pharma (ACST)?
The diluted earnings per share (EPS) of Acasti Pharma (ACST) is -$0.30 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Acasti Pharma (ACST)?
The operating cash flow of Acasti Pharma (ACST) is -$4,239,000. Learn about cash flow.
What is the current ratio of Acasti Pharma (ACST)?
The current ratio of Acasti Pharma (ACST) is 6.01, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Acasti Pharma (ACST)?
The operating income of Acasti Pharma (ACST) is -$4,831,000. Learn about operating income.